LTFS
MDCO

Ladenburg Thalmann Financial Services’s Medicines Co MDCO Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$126K Buy
1,489
+441
+42% +$29.4K ﹤0.01% 2853
2019
Q3 		$52K Sell
1,048
-1,478
-59% -$59K ﹤0.01% 3426
2019
Q2 		$92K Buy
2,526
+381
+18% +$12.4K ﹤0.01% 3032
2019
Q1 		$60K Buy
2,145
+146
+7% +$3.44K ﹤0.01% 3285
2018
Q4 		$38K Sell
1,999
-385
-16% -$8.96K ﹤0.01% 3456
2018
Q3 		$71K Sell
2,384
-131
-5% -$4.94K ﹤0.01% 3096
2018
Q2 		$83K Hold
2,515
– – ﹤0.01% 2874
2018
Q1 		$83K Buy
2,515
+102
+4% +$3.19K ﹤0.01% 2874
2017
Q4 		$66K Buy
2,413
+32
+1% +$986 ﹤0.01% 3039
2017
Q3 		$89K Sell
2,381
-162
-6% -$5.97K ﹤0.01% 2688
2017
Q2 		$97K Buy
2,543
+1,143
+82% +$50.9K ﹤0.01% 2534
2017
Q1 		$69K Buy
1,400
+180
+15% +$8.21K ﹤0.01% 2666
2016
Q4 		$42K Buy
1,220
+466
+62% +$16.5K ﹤0.01% 2977
2016
Q3 		$29K Hold
754
– – ﹤0.01% 3174
2016
Q2 		$26K Sell
754
-46
-6% -$1.62K ﹤0.01% 3168
2016
Q1 		$25K Buy
800
+80
+11% +$2.61K ﹤0.01% 3115
2015
Q4 		$27K Sell
720
-27
-4% -$1.02K ﹤0.01% 3019
2015
Q3 		$28K Sell
747
-35
-4% -$1.23K ﹤0.01% 2892
2015
Q2 		$22K Buy
782
+334
+75% +$9.3K ﹤0.01% 3193
2015
Q1 		$13K Sell
448
-300
-40% -$8.43K ﹤0.01% 3475
2014
Q4 		$20K Buy
748
+300
+67% +$7.43K ﹤0.01% 2995
2014
Q3 		$10K Sell
448
-24
-5% -$610 ﹤0.01% 3116
2014
Q2 		$14K Sell
472
-156
-25% -$4.17K ﹤0.01% 2911
2014
Q1 		$18K Buy
628
+76
+14% +$2.52K ﹤0.01% 2656
2013
Q4 		$21K Sell
552
-20
-3% -$715 ﹤0.01% 2516
2013
Q3 		$19K Buy
572
+41
+8% +$1.31K ﹤0.01% 2497
2013
Q2 		$17K Buy
+531
New +$17.8K ﹤0.01% 2446

Other funds holding MDCO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Ladenburg Thalmann Financial Services's MDCO Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Medicines Co (MDCO) stake by 42% in Q4 2019, buying an estimated $29.4K and bringing the position to 1,489 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #2853.

Ladenburg Thalmann Financial Services first reported a position in MDCO in Q2 2013 and has held it in 27 quarters since. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 1,489 shares of Medicines Co worth $126K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 441 Medicines Co shares in Q4 2019, an estimated $29.4K.
  • Medicines Co made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #2853 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Medicines Co in Q2 2013 and has held it in 27 quarters since.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.